Track topics on Twitter Track topics that are important to you
Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...
Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...
When it comes to hard-to-reach blood clots, endovascular therapy is an effective—and superior—method to medical management, according to a recent study by the University of Texas Health Science Ce...
The first long-term results from the new crop of endovascular trials in stroke show consistent benefit on functional outcomes and suggest a reduction in mortality. Medscape Medical News
SAINT HELIER (dpa-AFX) - Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transact...
A 200-patient, multisite clinical trial has been launched by Wayne, Pa.-based Intact Vascular to assess its Tack endovascular -More-
Dr Brown leads a multidisciplinary expert panel discussion of endovascular treatment for acute stroke, covering patient selection and imaging to avoiding complications. Mayo Clinic
The European Commission has approved under the EU Merger Regulation a proposed merger between IMS Health…
Transgenomic, Inc. , and privately-held Precipio Diagnostics, LLC today announced entry into a merger agreement, pursuant to which Precipio will become a wholly owned subsidiary of Transgenomic, and T...
Monsanto has agreed to a $57 billion cash offer from Bayer…
To evaluate the differences in technical outcomes and secondary interventions between elective endovascular aneurysm repair (el-EVAR) procedures and those for ruptured aneurysms (r-EVAR).
To determine the efficacy of thoracic endovascular aortic repair (TEVAR) for degenerative aneurysm involving only the descending thoracic aorta (DTAA).
To present a new endovascular technique to avoid open surgical arch reconstruction in selected patients with aneurysmal dilatation due to small chronic dissection entries in the aortic arch.